The following data is part of a premarket notification filed by Mecta Corporation with the FDA for Mecta Sigma.
| Device ID | K192834 |
| 510k Number | K192834 |
| Device Name: | MECTA Sigma |
| Classification | Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder |
| Applicant | Mecta Corporation 19799 SW 95th Ave. Tualatin, OR 97062 |
| Contact | Robin Nicol |
| Correspondent | Robin Nicol MECTA Corporation 19799 SW 95th Ave Tualatin, OR 97062 |
| Product Code | QGH |
| CFR Regulation Number | 882.5940 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Special |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 2019-10-02 |
| Decision Date | 2020-04-26 |
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 00850045508012 | K192834 | 000 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() MECTA SIGMA 88788300 not registered Live/Pending |
Mecta Corporation 2020-02-06 |
![]() MECTA SIGMA 88377400 not registered Live/Pending |
Mecta Corporation 2019-04-09 |
![]() MECTA SIGMA 88267318 not registered Live/Pending |
Mecta Corporation 2019-01-18 |